DNA Binding Ligands with Improved in Vitro and in Vivo Potency against Drug-Resistant <i>Staphylococcus aureus</i>

Wenhao Hu, Roland W. Bürli, Jacob A. Kaizerman, Kirk W. Johnson, Matthew Gross, Mari Iwamoto, Peter Jones, Denene Lofland, Stacey Difuntorum, Hsiu Chen,

Journal of Medicinal Chemistry · 2004 · 25 citations · 12 references

Concepts

Abstract

Potent in vivo activity against methicillin-resistant Staphylococcus aureus (MRSA) has been difficult to achieve with previously reported DNA binding antibacterials. Herein, we describe an efficient access to a focused library of new analogues yielding compounds with improved activity in a mouse peritonitis model. The most potent molecules (14 and 19) exhibit efficacy against MRSA at ED50 values of approximately 1 and approximately 5 mg/kg, respectively, and display excellent in vitro activity against vancomycin-resistant S. aureus.

References

12